WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Tennessee schools would have to out transgender students to parents under bill heading to governor'Goal' Palmer scores four in 6Closing prices for crude oil, gold and other commoditiesZion Williamson, at long last, set to suit up for the Pelicans in the NBA postseasonInaugural Golden Panda Awards aims to boost global cultural exchangesChina's Yangtze River sees improved water quality in 2023New rules to help improve flow of dataWomen's soccer coach accused of sexual harassment in Brazil resigns after protestsBuffalo, New York: Remains of missing 12Abu Ghraib detainee shares emotional testimony during trial against Virginia military contractor
2.7388s , 6504.2421875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,International Iterations news portal